Insulet Corp (PODD)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012292
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin infusion device and the Personal Diabetes Manager, a handheld wireless device. Its OmniPod is a tubeless insulin pump that has two parts and a fully-automated cannula insertion. The company’s delivery systems business collaborates with several global pharmaceutical and biotechnology companies to adapt the OmniPod technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company markets its products in the US, Europe, and Asia through direct sales and distribution partners. Insulet is headquartered in Bedford, Massachusetts, the US.

Insulet Corp (PODD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Insulet Corp, Medical Devices Deals, 2011 to YTD 2017 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Insulet Corp, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Insulet Raises Private Placement of Senior Notes for USD345 Million 11
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 12
Asset Transactions 14
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 14
Acquisition 15
Insulet Acquires Neighborhood Diabetes 15
Insulet Corp – Key Competitors 16
Insulet Corp – Key Employees 17
Insulet Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 02, 2017: Insulet Reports Third Quarter 2017 Financial Results 19
Aug 03, 2017: Insulet Reports Second Quarter 2017 Financial Results 20
May 08, 2017: Insulet Reports First Quarter 2017 Financial Results 21
Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 22
Aug 03, 2016: Insulet Reports Second Quarter 2016 Financial Results 24
May 03, 2016: Insulet Reaffirms Second Quarter and Full Year 2016 Guidance 25
Apr 28, 2016: Insulet Reports First Quarter 2016 Financial Results 26
Feb 25, 2016: Insulet Reports Fourth Quarter and Full Year 2015 Financial Results 27
Corporate Communications 29
Aug 10, 2017: Insulet Appoints Michael R. Minogue and James C. Mullen to Board of Directors 29
May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer 30
Oct 19, 2016: Insulet Announces Board and Management Changes 31
Feb 09, 2016: Insulet Appoints David A. Lemoine to Board of Directors 32
Other Significant Developments 33
Sep 06, 2016: Insulet to Establish Highly-Automated Manufacturing Operation in the United States 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Insulet Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Insulet Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Insulet Corp, Medical Devices Deals, 2011 to YTD 2017 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Insulet Raises Private Placement of Senior Notes for USD345 Million 11
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 12
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 14
Insulet Acquires Neighborhood Diabetes 15
Insulet Corp, Key Competitors 16
Insulet Corp, Key Employees 17
Insulet Corp, Subsidiaries 18

★海外企業調査レポート[Insulet Corp (PODD)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ten Network Holdings Ltd:企業の戦略的SWOT分析
    Ten Network Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Treeway BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Treeway BV (Treeway) is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis (ALS). The company provides pipeline products such as TW001, an oral formulation of edaravone, which protects against neuronal apoptosis and oxidative stress. It offers prod …
  • Jackson Electric Membership Corporation:企業の戦略的SWOT分析
    Jackson Electric Membership Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • OncoTherapy Science Inc (4564):医療機器:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Manulife Financial Corporation:企業のM&A・事業提携・投資動向
    Manulife Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Manulife Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • The Bank of East Asia, Limited:企業の戦略・SWOT・財務情報
    The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PT Kalbe Farma Tbk (KLBF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises br …
  • Digital Realty Trust Inc:企業のM&A・事業提携・投資動向
    Digital Realty Trust Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Digital Realty Trust Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Hyundai Rotem Co
    Hyundai Rotem Co - Strategy, SWOT and Corporate Finance Report Summary Hyundai Rotem Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PT Tiphone Mobile Indonesia Tbk (TELE):企業の財務・戦略的SWOT分析
    PT Tiphone Mobile Indonesia Tbk (TELE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Rosenergoatom Concern JSC:企業の戦略的SWOT分析
    Rosenergoatom Concern JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Virginia Electric and Power Co:企業の戦略的SWOT分析
    Virginia Electric and Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • PUMA SE:企業の戦略・SWOT・財務情報
    PUMA SE - Strategy, SWOT and Corporate Finance Report Summary PUMA SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Austin Exploration Limited (AKK)-石油・ガス分野:企業M&A・提携分析
    Summary Austin Exploration Limited (Austin) is upstream oil and gas company that acquires, explores, develops, and produces oil and natural gas in the US. The company holds working interests in Colorado in the DJ Basin with the Niobrara and Pierre Shale as its primary oil and gas formations. It also …
  • Iberdrola Ingenieria y Construccion SAU:企業の戦略・SWOT・財務情報
    Iberdrola Ingenieria y Construccion SAU - Strategy, SWOT and Corporate Finance Report Summary Iberdrola Ingenieria y Construccion SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Costco Wholesale Corporation:企業の戦略・SWOT・財務分析
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Noor Takaful:企業の戦略・SWOT・財務分析
    Noor Takaful - Strategy, SWOT and Corporate Finance Report Summary Noor Takaful - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Biosceptre International Ltd:企業の製品パイプライン分析2018
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of va …
  • C&S Wholesale Grocers, Inc.:企業の戦略・SWOT・財務分析
    C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report Summary C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆